Commission Implementing Regulation (EU) 2022/814 of 20 May 2022 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval period of the active substance heptamaloxyloglucan
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
EU legal act incorporated into the EEA Agreement by a Joint Committee Decision (JCD)
Area (EEA Agreement)
II Technical Regulations, Standards, Testing and Certification
II.XV Dangerous Substances
Joint committee decision (JCD)
011/2023
In force in the EEA
Yes
Legal Documents
Commission Implementing Regulation (EU) 2022/814 of 20 May 2022 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval period of the active substance heptamaloxyloglucan
Framkvæmdarreglugerð framkvæmdastjórnarinnar (ESB) 2022/814 frá 20. maí 2022 um breytingu á framkvæmdarreglugerð (ESB) nr. 540/2011 að því er varðar framlengingu á samþykkistímabilinu fyrir virka efnið heptamaloxýlóglúkan
Durchführungsverordnung (EU) 2022/814 der Kommission vom 20. Mai 2022 zur Änderung der Durchführungsverordnung (EU) Nr. 540/2011 hinsichtlich der Verlängerung der Dauer der Genehmigung für den Wirkstoff Heptamaloxyloglucan
Kommisjonens gjennomføringsforordning (EU) 2022/814 av 20. mai 2022 om endring av gjennomføringsforordning (EU) nr. 540/2011 med hensyn til forlengelse av godkjenningsperioden for det aktive stoffet heptamaloksyloglukan
History
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.